The Center for Healthcare Value (CHV)

The Center for Healthcare Value
The Center for Healthcare Value (CHV) is focused on advancing rational, science-driven and clinician-tested healthcare solutions that reduce cost and improve quality.
Training: Teaching to Choose Wisely
The CHV Training Initiative is reshaping clinical education to ensure the next generation of healthcare leaders understand the importance of value and how to create it.
Caring Wisely™
Caring Wisely is an organized process for engaging and supporting frontline clinicians in efforts to remove unnecessary costs from healthcare delivery systems.

Research and Policy
The CHV Research and Policy Initiative supports multi-center and multi-stakeholder projects that define high-value care and incentivize its adoption to demonstrate that value can be improved across the system
Delivery Systems: Measuring Value
The CHV Measuring Value Initiative is a partnership between front-line practitioners, financial data analysts, and executive stakeholders to build a standardized approach to accurately assess the clinical benefits and cost savings of value-based initiatives at UCSF.

Reduce costs | Increase value | Enable innovation


Teaching to Choose Wisely 2018

The UCSF Center for Healthcare Value (CHV) is pleased to again sponsor the “Teaching to Choose Wisely” initiative, making awards to faculty, staff and trainees for collaborative proposals responsive to two priority areas outlined by the CHV Training Initiative: 

  • developing educators with focused expertise in teaching the principles and practice of healthcare value
  • training healthcare leaders to promote high-value, cost-conscious care at all levels, from the greater system to individual clinician/patient interactions

The CHV will select 1 or 2 one-year projects that have the greatest potential to meet the intended goals of the priority areas. Funds are available to support up to $7500 per proposal. 

Application deadline is April 30, 2018Full details are can be found at:
https://open-proposals.ucsf.edu/chv/teaching-choose-wisely-2018 
 



High Value Care Seminar Series, 2018
Sponsored by the UCSF Center for Healthcare Value

View Video Series here

 


Featured stories:

More Access to HealthCare: Opportunities for Leadership in Value, Quality, and Equity.
Claire Brindis DrPH, Director, Philip R. Lee Institute for Health Policy Studies at UCSF
San Francisco Marin Medicine, March 2018 Read more 

 

 

 

 

 

 

 

 

 

 


Amazon, Buffett, JPMorgan Join Forces on Health Care

R. Adams Dudley, MD
R. Adams Dudley, MD, director of the UCSF Center for Healthcare Value, comments on the proposed plan for three of America's biggest companies to create a new company to provide employees with high-quality, affordable healthcare.

 


Soaring Drug Prices: How They Impact Consumers and What Can Be Done

Drug pricesDrug prices in the United States are twice what they are in the United Kingdom and are much higher than in all other developed countries. In addition, drug prices are rising faster than prices for general consumer products or even other health care products. In this panel, Lisa Gill from Consumer Reports will describe the impact on patients.  R. Adams Dudley, MD, from UCSF, will describe the consequences of high or expensive drug costs on patients with severe or chronic health conditions.  Finally, Robin Feldman from UC Hastings will outline the role of patent law and market forces in driving prices higher. The panel and the audience will then discuss policy options to address high drug prices.

Video: UCSF Presentation by Lisa Gill and R. Adams Dudley, MD
Video: Capitol Insights: A UC Center Sacramento Panel Discussion


Pelvic ExamsEffect of professional society recommendations on women's desire for a routine pelvic examination

One group of doctors, represented by the American College of Obstetricians and Gynecologists, recommends yearly pelvic exams for all women 21 years of age and older, whether they have symptoms of disease or not.

But the American College of Physicians, representing doctors of internal medicine, says that potential harms of the exam outweigh benefits and recommends against performing pelvic examinations unless a woman is pregnant or has symptoms of disease such as bleeding, pain or signs of infection.